Back
Evoke Pharma Stock Price Chart
Sponsored
EVOK
Sponsored
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
EVOK
Evoke Pharma
Last Price:
5.35
Seasonality Move:
-7.28%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EVOK is experiencing slight selling pressure.
Evoke Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.97 | Buy |
20-day SMA: | 4.62 | Buy |
50-day SMA: | 4.83 | Buy |
200-day SMA: | 6.81 | Sell |
8-day EMA: | 4.99 | Buy |
20-day EMA: | 4.79 | Buy |
50-day EMA: | 4.96 | Buy |
200-day EMA: | 7.94 | Sell |
Evoke Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 59.82 | Buy |
Chaikin Money Flow: | -82214 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.07 - 4.95) | Buy |
Bollinger Bands (100): | (4.63 - 6.39) | Sell |
Evoke Pharma Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Evoke Pharma Stock
Is Evoke Pharma Stock a Buy?
- Evoke Pharma share price is 5.25 while EVOK 8-day simple moving average is 4.97, which is a Buy signal.
- The stock price of EVOK is 5.25 while Evoke Pharma 20-day SMA is 4.62, which makes it a Buy.
- Evoke Pharma 50-day simple moving average is 4.83 while EVOK share price is 5.25, making it a Buy technically.
- EVOK stock price is 5.25 and Evoke Pharma 200-day simple moving average is 6.81, creating a Sell signal.
EVOK Technical Analysis vs Fundamental Analysis
Sell
37
Evoke Pharma (EVOK)
is a Sell
Is Evoke Pharma a Buy or a Sell?
-
Evoke Pharma stock is rated a Sell
The current Evoke Pharma [EVOK] share price is $5.25. The Score for EVOK is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Evoke Pharma Stock Info
Market Cap:
3.86M
Price in USD:
5.25
Share Volume:
218.57K
Evoke Pharma 52-Week Range
52-Week High:
17.88
52-Week Low:
3.54
Sell
37
Evoke Pharma (EVOK)
is a Sell
Evoke Pharma Share Price Forecast
-
What is the Evoke Pharma stock price today?
The Evoke Pharma stock price is 5.25 USD today. -
Will EVOK stock go up or go down?
Evoke Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is Evoke Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Evoke Pharma is overvalued.
Is Evoke Pharma Stock a Buy?
- Evoke Pharma share price is 5.25 while EVOK 8-day exponential moving average is 4.99, which is a Buy signal.
- The stock price of EVOK is 5.25 while Evoke Pharma 20-day EMA is 4.79, which makes it a Buy.
- Evoke Pharma 50-day exponential moving average is 4.96 while EVOK share price is 5.25, making it a Buy technically.
- EVOK stock price is 5.25 and Evoke Pharma 200-day simple moving average is 7.94, creating a Sell signal.
Fundamental Analysis of Evoke Pharma
Is Evoke Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $24.34 per share, and an increase next year of $2.66 per share.
Technical Analysis of Evoke Pharma
Should I short Evoke Pharma stock?
- EVOK Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Evoke Pharma is a Buy
- Evoke Pharma Relative Strength Index (RSI) is 59.82, which suggest Evoke Pharma is overbought
- The Bollinger Bands (25) for Evoke Pharma is (4.07 - 4.95), which suggest Evoke Pharma is a Sell
- The Bollinger Bands (100) for Evoke Pharma is (4.63 - 6.39), which suggest Evoke Pharma is a Sell
* Evoke Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.